Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Elizabeth A. Bergsrud"'
Publikováno v:
Journal of Thrombosis and Thrombolysis. 16:175-188
Ximelagatran, an oral direct thrombin inhibitor, has been investigated for the prevention and treatment of venous thromboembolism as well as for anticoagulation in atrial fibrillation. Unique properties of ximelagatran are that it is a prodrug, it do